“…We, therefore, identified a set of core mutant PRGs ( n = 131) contributing to high-level resistance evolution through the phenotype-genotype atlas. In addition to the well-characterized ARGs, e.g., pdeR involved in biofilm formation 38 , ycjV involved in efflux pump 35,39 , MJ1187 involved in drug inactivation 40 , yafK involved in target bypass 41,42 , and yjiR involved in transcriptional reprogramming 43 , others may confer high-level resistance via unreported mechanisms, e.g., metH , ynfB , ulaG , ftsK , rtcR , and hflK . By locating these understudied core mutant PRGs in the gene co-fitness interaction network and analyzing the functions of interacted genes, their resistance mechanisms were proposed.…”